We sought to assess the role of oncogenic KRAS in the regulation of MYC expression in cell lines derived from lung and colorectal tumors and the effects of MYC on cellular cytotoxicity and drug sensitivity according to KRAS mutation status. The gene discussed is KRAS; the disease is colorectal neoplasm.